CNTG News and Press, Centogene N.V. From 05/08/20

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 08, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical comp...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 06, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical comp...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN,, May 05, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical com...

Just one IPO is scheduled for the week ahead, though there are a handful of deals in the IPO pipeline that are primed for May public offerings. Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after upsizing its deal...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Centogene N.V. (CNTG) Q4 2019 Earnings Conference Call April 23, 2020 08:00 AM ET Company Participants Sun Kim - Chief Strategy and IR Officer Arndt Rolfs - Chief Executive Officer Richard Stoffelen - Chief Financial Officer Conference Call Participants Sung Ji Nam - BTIG ...

Bausch Health Companies (NYSE: BHC ) initiated with Buy rating and $30 (84% upside) price target at Citigroup. Shares up  1%  premarket. More news on: Radius Health, Inc., Immunomedics, Inc., West Pharmaceutical Services, Inc., Healthcare stocks news, Stocks on the move, , Re...

The following slide deck was published by Centogene N.V. in conjunction with their 2019 Q4 earnings Read more ...

Centogene (NASDAQ: CNTG ): FY GAAP EPS of -€1.30. More news on: Centogene N.V., Earnings news and commentary, Healthcare stocks news, Read more ...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 23, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutica...